BioCentury
ARTICLE | Clinical News

APN201: Phase Ib started

March 5, 2012 8:00 AM UTC

Apeiron began a double-blind, placebo-controlled, Austrian Phase Ib trial to evaluate APN201 given prior to radiation therapy in about 20 patients. Apeiron has exclusive, worldwide rights to develop r...